Inceptionr LLC Has $544,000 Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Inceptionr LLC lowered its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 40.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 28,657 shares of the medical instruments supplier’s stock after selling 19,387 shares during the period. Inceptionr LLC’s holdings in DENTSPLY SIRONA were worth $544,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. FMR LLC lifted its position in shares of DENTSPLY SIRONA by 5.1% in the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after buying an additional 436,031 shares during the last quarter. Pacer Advisors Inc. lifted its position in shares of DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after buying an additional 4,473,972 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of DENTSPLY SIRONA by 27.9% in the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock worth $45,611,000 after buying an additional 523,692 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of DENTSPLY SIRONA by 1.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock worth $39,880,000 after buying an additional 35,360 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after buying an additional 1,244,326 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. Robert W. Baird reduced their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th. Needham & Company LLC dropped their price objective on DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating on the stock in a research note on Friday, February 28th. Wells Fargo & Company dropped their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Evercore ISI reiterated an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Finally, Barrington Research dropped their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $23.58.

DENTSPLY SIRONA Trading Up 0.4 %

XRAY stock opened at $16.32 on Friday. DENTSPLY SIRONA Inc. has a 1-year low of $15.47 and a 1-year high of $34.28. The firm has a market cap of $3.25 billion, a P/E ratio of -7.88, a P/E/G ratio of 1.80 and a beta of 0.98. The business’s 50 day moving average is $18.54 and its 200-day moving average is $21.18. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 3.92%. DENTSPLY SIRONA’s dividend payout ratio is currently -14.07%.

Insider Activity

In related news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction dated Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.52% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.